A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer

NCT00559845 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: 5-fluorouracil
DRUG: Epidoxorubicin
DRUG: Cyclophosphamide
DRUG: Paclitaxel
BIOLOGICAL: Bevacizumab

Sponsor

Hoffmann-La Roche